Skip to main content
. 2021 Jul 15;11:14519. doi: 10.1038/s41598-021-93654-2

Figure 5.

Figure 5

JNK-pathway activity and cell polarity are not altered in the absence of MarvelD3. (A) Detection of JNK, c-Jun and their phosphorylated forms in protein extracts from 3 wild-type (+ / +) and 3 MarvelD3 knockout (−/−) pancreata by western blotting. No differences in JNK, phospho-JNK (P-JNK), c-Jun and phospho-c-Jun (P–c-Jun, Ser63 and Ser73) protein levels were observed between wild-type and knockout pancreata. Quantification of the bands (P-JNK/JNK and P–c-Jun/c-Jun) is shown on the right. Full-length blots/gels are presented in Supplementary Fig. 8. (B) Cell polarity assessment by immunolabeling of apical (ezrin, red) and basal (laminin, green) markers of epithelial (E-Cadherin, white) cells on E15.5 embryonic pancreas sections. Wild-type (+ / +) and knockout (−/−) pancreatic epithelial cells are polarized. (C) RT-qPCR evaluation of tight junction and baso-lateral marker gene expression levels in embryonic (E15.5 and E17.5) pancreata of wild-type (+ / + , green circles), heterozygous (+ /−, orange squares) and MarvelD3 knockout (−/−, red triangles) mice. Transient downregulation of claudin-3 and -7, and NaK-ATPase (Atp1a) is observed in E15.5 knockouts. (D–E) Immunolabeling of the TAMP occludin and tricellulin (green) in the wild-type and knockout E15.5 pancreatic epithelium (E-Cadherin, red). The absence of MarvelD3 does not trigger relocalization of the two other TAMPs.